Publications

TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis.

Ford, N; Matteelli, A; Shubber, Z; Hermans, S; Meintjes, G; Grinsztejn, B; Waldrop, G; KRANZER, K; Doherty, M; Getahun, H;

2016

Journal of the International AIDS Society, (2016).19 1 10.7448/IAS.19.1.20714.

The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study.

Bailey, SL; AYLES, H; Beyers, N; GODFREY-FAUSSETT, P; Muyoyeta, M; Du Toit, E; Yudkin, JS; FLOYD, S;

2016

BMC infectious diseases, (2016).16 1 10.1186/s12879-016-2066-1.

TB vaccine development and the End TB Strategy: importance and current status.

FLETCHER, HA; Schrager, L;

2016

Transactions of the Royal Society of Tropical Medicine and Hygiene, (2016).110 4 10.1093/trstmh/trw016.

Plasma Membrane Profiling Reveals Upregulation of ABCA1 by Infected Macrophages Leading to Restriction of Mycobacterial Growth.

Long, J; BASU ROY, R; Zhang, YJ; Antrobus, R; Du, Y; Smith, DL; Weekes, MP; Javid, B;

2016

FRONTIERS IN MICROBIOLOGY, (2016).7 JUL 10.3389/fmicb.2016.01086.

A reanalysis of the Brazil XpertMTB/RIF stepped wedge trial using a novel cluster summary analysis method.

THOMPSON, JA; DAVEY, C; FIELDING, K; HARGREAVES, J; HAYES, RJ;

2016

Current developments in cluster randomised trials and stepped wedge designs (2016).

A role for mycobacterial blood culture and molecular analysis of lymph node tissue.

Jolobe, OM; Bharucha, T; Cockbain, B; BROWN, M;

2016

British journal of hospital medicine (London, England, (2016).77 12 10.12968/hmed.2016.77.12.724.

TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.

HOUBEN, RM G J; LALLI, M; SUMNER, T; Hamilton, M; PEDRAZZOLI, D; Bonsu, F; Hippner, P; Pillay, Y; Kimerling, M; Ahmedov, S; Pretorius, C; WHITE, RG;

2016

BMC medicine, (2016).14 1 10.1186/s12916-016-0608-4.

Tuberculosis screening in patients with HIV: An audit against UK national guidelines to assess current practice and the effectiveness of an electronic tuberculosis-screening prompt.

Fox-Lewis, A; Brima, N; Muniina, P; GRANT, AD; Edwards, SG; Miller, RF; Pett, SL;

2016

International journal of STD & AIDS, (2016).27 10 10.1177/0956462416628355.

Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.

Gomez, GB; Dowdy, DW; Bastos, ML; Zwerling, A; SWEENEY, S; FOSTER, N; Trajman, A; Islam, MA; KAPIGA, S; Sinanovic, E; KNIGHT, GM; WHITE, RG; Wells, WA; Cobelens, FG; VASSALL, A;

2016

BMC infectious diseases, (2016).16 1 10.1186/s12879-016-2064-3.

A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Zak, DE; Penn-Nicholson, A; Scriba, TJ; Thompson, E; Suliman, S; Amon, LM; Mahomed, H; Erasmus, M; Whatney, W; Hussey, GD; Abrahams, D; Kafaar, F; Hawkridge, T; Verver, S; Hughes, EJ; Ota, M; SUTHERLAND, J; Howe, R; DOCKRELL, HM; Boom, WH; Thiel, B; Ottenhoff, TH M; Mayanja-Kizza, H; CRAMPIN, AC; Downing, K; ... ACS and GC6-74 cohort study groups,

2016

Lancet, (2016).387 10035 10.1016/S0140-6736(15)01316-1.